341/636US=35 / Biol/Mol
McCormick F, Korn WM. Gene therapy and oncolytic viruses. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 679-90. ISBN 978-1-4160-3703-3.

VIRUS ONCOLITICOS; TERAPIA GENETICA; MORTE DAS CELULAS CANCERIGENAS

342/636US=23-A / Câncer
Kettunen MI, Grohn OHJ. Tumor gene therapy: magnetic resonance imaging and magnetic resonance spectroscopy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 39-53. ISBN 978-1-4020-8441-62.

CANCER; TERAPIA GENETICA; RESSONANCIA MAGNETICA; ESPECTROSCOPIA

343/636US=23-A / Câncer
Altmann A, Haberkorn U. Assessment of gene transfer: magnetic resonance imaging and nuclear medicine techniques. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 55-73. ISBN 978-1-4020-8441-62.

CANCER; TRANSFERENCIA DE GENES; RESSONANCIA MAGNETICA; MEDICINA NUCLEAR

344/636US=23-A / Câncer
Toledo F. Role of TP53 mutations in cancer (an overview). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 75-92. ISBN 978-1-4020-8441-62.

CANCER; MUTACAO; GENE TP53; CAPACIDADE DE TRANSATIVACAO P53

345/636US=23-A / Câncer
Bartolazzi A. Non-small cell lung carcinoma: EGFR gene mutations and response to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 291-306. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; MUTACOES EGFR; GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO

346/636US=23-A / Câncer
Ma ESK, Wong CLP. Non-small cell lung cancer with brain metastasis: role of epidermal growth factor receptor gene mutation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 371-87. ISBN 978-1-4020-8441-62.

CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; METASTASE CEREBRAL; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; MUTACAO DO GENE

347/636US=30 / Clín/Medica
Bueris V. Genética da virilência. In: Trabulsi LR, Alterthum F. Microbiologia. 5ª ed. São Paulo: Atheneu, 2008. p. 163-8. ISBN 85-7379981-1.

GENE DE VIRULENCIA; EXPRESSAO DO GENE; CLONE PATOGENICO

348/636US=33 / Biol/Mol
Lewin B. Genes are DNA. In: ___. Genes IX. Boston: Jones & Bartlett Publishers, 2008. p. 1-22. ISBN 0-7637-5222-3.

GENE; DNA; GENOMA; MATERIAL GENETICO; CADEIAS POLINUCLEOTIDICAS; FOSFATO DE BACKBONE; REPLICACAO DO DNA; INFORMACAO GENETICA; HIBRIDIZACAO DOS ACIDOS NUCLEICOS; MUTACAO

349/636US=33 / Biol/Mol
Lewin B. The interrrupted gene. In: ___. Genes IX. Boston: Jones & Bartlett Publishers, 2008. p. 37-54. ISBN 0-7637-5222-3.

GENES INTERROMPIDOS; EXONS; INTRONS; MAPEAMENTO DE DNA; FUNCAO PROTEICA; INFORMACAO GENETICA

350/636US=33 / Biol/Mol
Lewin B. Genome sequences and gene numbers. In: ___. Genes IX. Boston: Jones & Bartlett Publishers, 2008. p. 76-97. ISBN 0-7637-5222-3.

SEQUENCIAS DO GENOMA; NUMEROS DE GENES; GENOMA HUMANO

351/636US=33 / Biol/Mol
Lewin B. Transcription. In: ___. Genes IX. Boston: Jones & Bartlett Publishers, 2008. p. 256-99. ISBN 0-7637-5222-3.

TRANSCRICAO DE GENE; POLIMERASE DE RNA; MUTACAO; FATORES SIGMA

352/636US=39 / Câncer
Förster Y, Schwenzer B. Antisense oligonucleotides and siRNA as specific inhibitors of gene expression: mechanisms of action and therapeutic potential. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 337-62. ISBN 978-1-58829-989-5.

OLIGONUCLEOTIDOS ANTI-SENTIDO; SIRNA COMO INIBIDORES ESPECIFICOS; EXPRESSAO DO GENE; MECANISMOS DE ACAO; POTENCIAL TERAPEUTICO

353/636Câncer
Schiavon BN, Vassallo J, Rocha RM. Is polysomy 17 an important phenomenon to predict treatment with trastuzumab in breast cancer ?. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.4, p. 138-42, 2011. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.138-42.pdf

NEOPLASIAS DA MAMA; HER-2; HIBIDIZACAO; POLISOME; TRASTUZUMAB; FLUORESCENCIA

354/636US=4 / Câncer
Garicochea B. Biologia molecular da célula tumoral. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 29-38. ISBN 85-3631168-5.

NEOPLASIA; CANCER; BIOLOGIA MOLECULAR; CICLO CELULAR; ONCOGENE; GENES SUPRESSORES DE TUMOR; APOPTOSE; GENE DE REPARO DO DNA; LESAO GENICA

355/636US=4 / Câncer
Silva RLA, Ferreira CG. Oncogenes. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 39-50. ISBN 85-3631168-5.

ONCOGENE. CARACTERISTICAS; GENE SUPRESSOR DE TUMOR. CARACTERISTICAS; ONCOGENES VIRAIS; ONCOGENES CELULARES

356/636US=436 / Tese/FAP
Molina GC. Identificação de marcadores moleculares de prognóstico para adenocarcinoma de próstata utilizando abordagem quantitativa baseada em sequências. [Identification of prognostic molecular markers for prostate adenocarcinoma exploiting a quantitative approach based on sequencing]. São Paulo, 2012. 116 p. Tese(Doutorado)-Fundação Antonio Prudente.

Disponível em: http://accamargo.phlnet.com.br/Doutorado/2012/GustavoMolina/GustavoMolina.pdf

Curriculum Lattes

MARCADORES BIOLOGICOS; NEOPLASIAS DA PROSTATA; SEQUENCIAMENTO; EXPRESSAO GENICA; PROGNOSTICO

357/636US=42 / Biol/Mol
Camenisch U, Nägeli H. XPA gene, its product and biological roles. In: Ahmad SI, Hanaoka F. Molecular mechanisms of xeroderma pigmentosum. New York: Springer, 2008. p. 28-38. (Advances in Experimental Medicine and Biology, 637) ISBN 978-0-387-09598-1.

XERODERMA PIGMENTOSO; GENE; GENE XPA

358/636US=42 / Biol/Mol
Bennett D, Itoh T. The XPE gene of xeroderma pigmentosum, its product and biological roles. In: Ahmad SI, Hanaoka F. Molecular mechanisms of xeroderma pigmentosum. New York: Springer, 2008. p. 57-64. (Advances in Experimental Medicine and Biology, 637) ISBN 978-0-387-09598-1.

XERODERMA PIGMENTOSO; GENE XPE

359/636US=42 / Gastro
Whitcomb DC. Cystic fibrosis-associated pancreatitis. In: Beger H, Warshaw A, Büchler M, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Whitcomb DC, Rau BM. The pancreas: an integrated textbook of basic science, medicine, and surgery. 2nd ed. Massachuetts: Blackwell Scientific Publications, 2008. p. 427-36. ISBN 978-1-4051-4664-7.

PANCREATITE; FIBROSE CISTICA; MUTACAO DO GENE CFTR

360/636US=42 / Gastro
Costello E. Molecular biological understanding of development of pancreatic cancer. In: Beger H, Warshaw A, Büchler M, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Whitcomb DC, Rau BM. The pancreas: an integrated textbook of basic science, medicine, and surgery. 2nd ed. Massachuetts: Blackwell Scientific Publications, 2008. p. 583-90. ISBN 978-1-4051-4664-7.

CANCRO PANCREATICO; BIOLOGIA MOLECULAR; VIAS ONCOGENICAS; GENE SUPRESSOR DE TUMOR

Primeira | Anterior | Próxima | Última